Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 578107, 10 pages
http://dx.doi.org/10.1155/2015/578107
Review Article

Rhein: A Review of Pharmacological Activities

1Central Laboratory, Shanghai Seventh People’s Hospital, Shanghai 200137, China
2Key Laboratory of Standardization of Chinese Herbal Medicines of Ministry of Education, Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
3Department of Nuclear Medicine, Shanghai Seventh People’s Hospital, Shanghai 200137, China
4School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool L3 3AF, UK
5Department of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

Received 7 March 2015; Revised 13 May 2015; Accepted 25 May 2015

Academic Editor: Antonella Fioravanti

Copyright © 2015 Yan-Xi Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Layek, T. S. Kumar, R. K. Trivedi, R. Mullangi, and N. R. Srinivas, “Development and validation of a sensitive LC-MS/MS method with electrospray ionization for quantitation of rhein in human plasma: application to a pharmacokinetic study,” Biomedical Chromatography, vol. 22, no. 6, pp. 616–624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-Z. Guo, X.-S. Li, D.-M. Shen, X.-Q. Guan, H.-R. Xu, and J. Gao, “Effect of Rhein on the development of hepatic fibrosis in rats,” Zhonghua Gan Zang Bing Za Zhi, vol. 11, no. 1, pp. 26–29, 2003. View at Google Scholar · View at Scopus
  3. F. Moldovan, J. P. Pelletier, F.-C. Jolicoeur, J.-M. Cloutier, and J. Martel-Pelletier, “Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage,” Osteoarthritis and Cartilage, vol. 8, no. 3, pp. 186–196, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Du, J.-Q. Shao, P. Gu, J. Wang, and Z.-H. Liu, “Effect of early intervention with rhein on islet function in db/db mice,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 31, no. 9, pp. 1526–1529, 2011. View at Google Scholar · View at Scopus
  5. S.-K. Heo, H.-J. Yun, W.-H. Park, and S.-D. Park, “Rhein inhibits TNF-α-induced human aortic smooth muscle cell proliferation via mitochondrial-dependent apoptosis,” Journal of Vascular Research, vol. 46, no. 4, pp. 375–386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. Lin, J. G. Chung, Y. C. Lu, C. Y. Yang, and S. S. Chen, “Rhein inhibits invasion and migration of human nasopharyngeal carcinoma cells in vitro by down-regulation of matrix metalloproteinases-9 and vascular endothelial growth factor,” Oral Oncology, vol. 45, no. 6, pp. 531–537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-Y. Chen, S.-Y. Chiang, J.-G. Lin et al., “Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9,” International Journal of Oncology, vol. 36, no. 5, pp. 1113–1120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Shi, Z. Huang, and G. Chen, “Rhein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma BEL-7402 cells,” The American Journal of Chinese Medicine, vol. 36, no. 4, pp. 805–813, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. T. C. Hsia, J. S. Yang, G. W. Chen et al., “The roles of endoplasmic reticulum stress and Ca2+ on rhein-induced apoptosis in A-549 human lung cancer cells,” Anticancer Research, vol. 29, no. 1, pp. 309–318, 2009. View at Google Scholar · View at Scopus
  10. J.-C. Tang, H. Yang, X.-Y. Song et al., “Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes,” Phytotherapy Research, vol. 23, no. 2, pp. 159–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D.-X. Bian, J. Liu, L. Lu et al., “Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet,” Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, vol. 27, no. 5, pp. 328–331, 2013. View at Google Scholar · View at Scopus
  12. X. Sheng, M. Wang, M. Lu, B. Xi, H. Sheng, and Y. Q. Zang, “Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 300, no. 5, pp. E886–E893, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. A. Wynn, “Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases,” The Journal of Clinical Investigation, vol. 117, no. 3, pp. 524–529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-Z. Guo, X.-S. Li, H.-R. Xu, Z.-C. Mei, W. Shen, and X.-F. Ye, “Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats,” Acta Pharmacologica Sinica, vol. 23, no. 8, pp. 739–744, 2002. View at Google Scholar · View at Scopus
  15. D. He, L. Lee, J. Yang, and X. Wang, “Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy,” Biological and Pharmaceutical Bulletin, vol. 34, no. 8, pp. 1219–1226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-N. Peng, H.-H. Zeng, A.-X. Fu, X.-W. Chen, and Q.-X. Zhu, “Effects of rhein on intestinal epithelial tight junction in IgA nephropathy,” World Journal of Gastroenterology, vol. 19, no. 26, pp. 4137–4145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-N. Peng, H.-H. Zeng, A.-X. Fu, X.-W. Chen, and Q.-X. Zhu, “Protection of rhein on IgA nephropathy mediated by inhibition of fibronectin expression in rats,” Indian Journal of Pharmacology, vol. 45, no. 2, pp. 174–179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Su, L. P. Yin, X. Zhang, B. B. Li, L. Liu, and H. Li, “Chronic allograft nephropathy in rats is improved by the intervention of rhein,” Transplantation Proceedings, vol. 45, no. 6, pp. 2546–2552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Q. Ji, C. W. Huang, C. J. Liang, W. W. Sun, B. Chen, and P. R. Tang, “Effects of rhein on activity of caspase-3 in kidney and cell apoptosis on the progression of renal injury in glomerulosclerosis,” Zhonghua Yi Xue Za Zhi, vol. 85, no. 26, pp. 1836–1841, 2005. View at Google Scholar · View at Scopus
  20. D.-Q. Yu, Y. Gao, and X.-H. Liu, “Effects of Rhein on the hypertrophy of renal proximal tubular epithelial cells induced by high glucose and angiotensin II in rats,” Zhong Yao Cai, vol. 33, no. 4, pp. 570–574, 2010. View at Google Scholar · View at Scopus
  21. C. Sanchez, M. Mathy-Hartert, M. A. Deberg, H. Ficheux, J.-Y. L. Reginster, and Y. E. Henrotin, “Effects of rhein on human articular chondrocytes in alginate beads,” Biochemical Pharmacology, vol. 65, no. 3, pp. 377–388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Borderie, A. Hernvann, H. Lemarechal, C.-J. Menkes, and O. Ekindjian, “Inhibition of the nitrosothiol production of cultured osteoarthritic chondrocytes by rhein, cortisol and diclofenac,” Osteoarthritis and Cartilage, vol. 9, no. 1, pp. 1–6, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-P. Pelletier, F. Mineau, J. C. Fernandes, N. Duval, and J. Martel-Pelletier, “Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes,” Journal of Rheumatology, vol. 25, no. 12, pp. 2417–2424, 1998. View at Google Scholar · View at Scopus
  24. J. Deffaud, M. Kirchmeyer, F. Domagala et al., “Modulatory effect of rhein on IL-1α-induced responses in human chondrocytes: a comparative study between antibody microarrays and specific ELISAs,” Biorheology, vol. 45, no. 3-4, pp. 439–455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-P. Pelletier, D. Lajeunesse, P. Reboul et al., “Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone,” Journal of Rheumatology, vol. 28, no. 4, pp. 814–824, 2001. View at Google Scholar · View at Scopus
  26. M. Yaron, I. Shirazi, and I. Yaron, “Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures,” Osteoarthritis and Cartilage, vol. 7, no. 3, pp. 272–280, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Martel-Pelletier, F. Mineau, F.-C. Jolicoeur, J.-M. Cloutier, and J.-P. Pelletier, “In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-α systems in human osteoarthritic synovium and chondrocytes,” The Journal of Rheumatology, vol. 25, no. 4, pp. 753–762, 1998. View at Google Scholar · View at Scopus
  28. C. Gigant-Huselstein, D. Dumas, E. Payan et al., “In vitro study of intracellular IL-1β production and β1 integrins expression in stimulated chondrocytes—effect of rhein,” Biorheology, vol. 39, no. 1-2, pp. 277–285, 2002. View at Google Scholar · View at Scopus
  29. F. Legendre, A. Heuze, K. Boukerrouche et al., “Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis,” Scandinavian Journal of Rheumatology, vol. 38, no. 2, pp. 104–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Martin, P. Bogdanowicz, F. Domagala, H. Ficheux, and J.-P. Pujol, “Rhein inhibits interleukin-1β-induced activation of MEK/ERK pathway and DNA binding of NF-κB and AP-1 in chondrocytes cultured in hypoxia: a potential mechanism for its disease-modifying effect in osteoarthritis,” Inflammation, vol. 27, no. 4, pp. 233–246, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Legendre, P. Bogdanowicz, G. Martin et al., “Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways,” Clinical and Experimental Rheumatology, vol. 25, no. 4, pp. 546–555, 2007. View at Google Scholar · View at Scopus
  32. A. F. Mendes, M. M. Caramona, A. P. de Carvalho, and M. C. Lopes, “Diacerhein and rhein prevent interleukin-1beta-induced nuclear factor-kappaB activation by inhibiting the degradation of inhibitor kappaB-alpha,” Pharmacology and Toxicology, vol. 91, no. 1, pp. 22–28, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Tamura, N. Kosaka, J. Ishiwa, T. Sato, H. Nagase, and A. Ito, “Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes,” Osteoarthritis and Cartilage, vol. 9, no. 3, pp. 257–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Tamura and K. Ohmori, “Rhein, an active metabolite of diacerein, suppresses the interleukin-1α-induced proteoglycan degradation in cultured rabbit articular chondrocytes,” Japanese Journal of Pharmacology, vol. 85, no. 1, pp. 101–104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Savarino, A. Fioravanti, G. Leo, R. Aloisi, and M. Mian, “Anthraquinone-2,6-disulfonic acid as a disease-modifying osteoarthritis drug: an in vitro and in vivo study,” Clinical Orthopaedics and Related Research, no. 461, pp. 231–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Hu, J. Liu, Y.-Z. Zhen et al., “Rhein inhibits the expression of vascular cell adhesion molecule 1 in human umbilical vein endothelial cells with or without lipopolysaccharide stimulation,” The American Journal of Chinese Medicine, vol. 41, no. 3, pp. 473–485, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. X.-D. Cong, M.-J. Ding, D.-Z. Dai, Y. Wu, Y. Zhang, and Y. Dai, “ER stress, P66shc, and P-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats,” Inflammation, vol. 35, no. 3, pp. 1031–1040, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Tamura, T. Yokoyama, and K. Ohmori, “Effects of diacerein on indomethacin-induced gastric ulceration,” Pharmacology, vol. 63, no. 4, pp. 228–233, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. X.-F. Zhong, G.-D. Huang, T. Luo, Z.-Y. Deng, and J.-N. Hu, “Protective effect of rhein against oxidative stress-related endothelial cell injury,” Molecular Medicine Reports, vol. 5, no. 5, pp. 1261–1266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. Y.-L. Zhao, G.-D. Zhou, H.-B. Yang et al., “Rhein protects against acetaminophen-induced hepatic and renal toxicity,” Food and Chemical Toxicology, vol. 49, no. 8, pp. 1705–1710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Glinn, C. P. Lee, and L. Ernster, “Pro- and anti-oxidant activities of the mitochondrial respiratory chain: factors influencing NAD(P)H-induced lipid peroxidation,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1318, no. 1-2, pp. 246–254, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Lin, J.-J. Li, M. Fujii, and D.-X. Hou, “Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway,” International Journal of Oncology, vol. 22, no. 4, pp. 829–833, 2003. View at Google Scholar · View at Scopus
  43. G. Aviello, I. Rowland, C. I. Gill et al., “Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells,” Journal of Cellular and Molecular Medicine, vol. 14, no. 7, pp. 2006–2014, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. V. E. Fernand, J. N. Losso, R. E. Truax et al., “Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro,” Chemico-Biological Interactions, vol. 192, no. 3, pp. 220–232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Y. Chen, S. Y. Chiang, J. G. Lin et al., “Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells,” Anticancer Research, vol. 30, no. 3, pp. 945–952, 2010. View at Google Scholar · View at Scopus
  46. S.-W. Ip, Y.-S. Weng, S.-Y. Lin, N.-Y. Tang, C.-C. Su, and J.-G. Chung, “The role of Ca+2 on rhein-induced apoptosis in human cervical cancer Ca Ski cells,” Anticancer Research, vol. 27, no. 1A, pp. 379–390, 2007. View at Google Scholar · View at Scopus
  47. S. Lin, M. Fujii, and D.-X. Hou, “Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway,” Archives of Biochemistry and Biophysics, vol. 418, no. 2, pp. 99–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. M.-L. Lin, S.-S. Chen, Y.-C. Lu et al., “Rhein induces apoptosis through induction of endoplasmic reticulum stress and Ca2+-dependent mitochondrial death pathway in human nasopharyngeal carcinoma cells,” Anticancer Research, vol. 27, no. 5, pp. 3313–3322, 2007. View at Google Scholar · View at Scopus
  49. F. Raimondi, P. Santoro, L. Maiuri et al., “Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro,” Journal of Pediatric Gastroenterology and Nutrition, vol. 34, no. 5, pp. 529–534, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. W. W. Lai, J. S. Yang, K. C. Lai et al., “Rhein induced apoptosis through the endoplasmic reticulum stress, caspase- and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells,” In Vivo, vol. 23, no. 2, pp. 309–316, 2009. View at Google Scholar · View at Scopus
  51. P. L. Kuo, Y. L. Hsu, L. T. Ng, and C. C. Lin, “Rhein inhibits the growth and induces the apoptosis of Hep G2,” Planta Medica, vol. 70, no. 1, pp. 12–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. Y.-H. Huang and Y.-S. Zhen, “Rhein induces apoptosis in cancer cells and shows synergy with mitomycin,” Yao Xue Xue Bao, vol. 36, no. 5, pp. 334–338, 2001. View at Google Scholar · View at Scopus
  53. H. Du, J. Shao, P. Gu, B. Lu, X. Ye, and Z. Liu, “Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice,” Journal of Endocrinological Investigation, vol. 35, no. 6, pp. 607–612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Du, J. Shao, P. Gu, B. Lu, J. Wang, and Z. Liu, “Effect of rhein treatment on first-phase insulin secretory function in db/db mice,” Zhongguo Zhongyao Zazhi, vol. 35, no. 20, pp. 2764–2767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Liu, Z. Chen, Y. Zhang et al., “Rhein protects pancreatic β-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia,” Diabetes, vol. 62, no. 11, pp. 3927–3935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Zhu, Z. Liu, and Y. Li, “Inhibition of glucose transporter 1 overexpression in mesangial cells by rhein,” Zhonghua Nei Ke Za Zhi, vol. 40, no. 8, pp. 537–542, 2001. View at Google Scholar · View at Scopus
  57. Z. H. Tan, Y. J. Shen, J. N. Zhao, H. Y. Li, and J. Zhang, “Effects of rhein on the function of human mesangial cells in high glucose environment,” Yaoxue XueBao, vol. 39, no. 11, Article ID 0513-4870(2004)11-0881-06, pp. 881–886, 2004. View at Google Scholar · View at Scopus
  58. Z. Liu, Y. Li, and J. Zhang, “Modulatory effect of transforming growth factor-beta and Rhein on glucose transporter-1 in human glomerular mesangial cells,” Zhonghua Yi Xue Za Zhi, vol. 79, no. 10, pp. 780–783, 1999. View at Google Scholar
  59. J. Zhang, Z. Liu, Z. Chen, Y. Li, and L. Li, “Effect of rhein on glucose transporter-1 expression and its function in glomerular mesangial cells,” Chinese Medical Journal, vol. 112, no. 12, pp. 1077–1079, 1999. View at Google Scholar · View at Scopus
  60. S. Castiglione, M. Fanciulli, T. Bruno et al., “Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions,” Anti-Cancer Drugs, vol. 4, no. 3, pp. 407–414, 1993. View at Publisher · View at Google Scholar · View at Scopus
  61. S. B. Choi, B. S. Ko, S. K. Park, and J. S. Jang, “Insulin sensitizing and α-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma,” Life Sciences, vol. 78, no. 9, pp. 934–942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. Z.-H. Liu, Y.-J. Li, Z.-H. Chen, D. Liu, and L.-S. Li, “Glucose transporter in human glomerular mesangial cells modulated by transforming growth factor-beta and rhein,” Acta Pharmacologica Sinica, vol. 22, no. 2, pp. 169–175, 2001. View at Google Scholar · View at Scopus
  63. J. G. Chung, M. F. Tsou, H. H. Wang et al., “Rhein affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients,” Journal of Applied Toxicology, vol. 18, no. 2, pp. 117–123, 1998. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Yu, H. Xiang, J. Fan et al., “Global transcriptional response of Staphylococcus aureus to Rhein, a Natural Plant Product,” Journal of Biotechnology, vol. 135, no. 3, pp. 304–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Leng-Peschlow, “Sennoside-induced secretion is not caused by changes in mucosal permeability or Na+, K+-ATPase activity,” Journal of Pharmacy and Pharmacology, vol. 45, no. 11, pp. 951–954, 1993. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Frieling, C. Rupprecht, and M. Schemann, “Rhein stimulates electrogenic chloride secretion by activation of submucosal neurons in guinea pig colon,” Pharmacology, vol. 47, no. 1, pp. 70–76, 1993. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Sheng, X. Zhu, Y. Zhang et al., “Rhein protects against obesity and related metabolic disorders through liver X receptor-mediated uncoupling protein 1 upregulation in brown adipose tissue,” International Journal of Biological Sciences, vol. 8, no. 10, pp. 1375–1384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. Q. Liu, X.-L. Zhang, R.-Y. Tao et al., “Rhein, an inhibitor of adipocyte differentiation and adipogenesis,” Journal of Asian Natural Products Research, vol. 13, no. 8, pp. 714–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. Z.-H. He, R. Zhou, M.-F. He et al., “Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei,” Phytomedicine, vol. 18, no. 6, pp. 470–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. Q. Wang, N.-N. Zhang, H.-Y. Li, M. Jiang, J. Gao, and G. Bai, “Active ingredients in rhubarb with anti-proliferative effects on scar fibroblasts,” Yaoxue Xuebao, vol. 47, no. 12, pp. 1618–1622, 2012. View at Google Scholar · View at Scopus
  71. F. A. Badria and A. S. Ibrahim, “Evaluation of natural anthracene-derived compounds as antimitotic agents,” Drug Discoveries & Therapeutics, vol. 7, no. 2, pp. 84–89, 2013. View at Publisher · View at Google Scholar
  72. Q. Gao, W.-S. Qin, Z.-H. Jia et al., “Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy,” Planta Medica, vol. 76, no. 1, pp. 27–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Peng, J. Yang, C. Ning et al., “Rhein inhibits integrin-linked kinase expression and regulates matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in high glucose-induced epithelial-mesenchymal transition of renal tubular cell,” Biological and Pharmaceutical Bulletin, vol. 35, no. 10, pp. 1676–1685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Liu, J. Cheng, X. Zheng et al., “Targeting CpG DNA to screen and isolate anti-sepsis fraction and monomers from traditional Chinese herbs using affinity biosensor technology,” International Immunopharmacology, vol. 9, no. 9, pp. 1021–1031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. S. C. Kang, C. M. Lee, E. S. Choung et al., “Anti-proliferative effects of estrogen receptor-modulating compounds isolated from Rheum palmatum,” Archives of Pharmacal Research, vol. 31, no. 6, pp. 722–726, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. S.-K. Heo, H.-J. Yun, E.-K. Noh, and S.-D. Park, “Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production,” Vascular Pharmacology, vol. 53, no. 1-2, pp. 28–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. B. Singh, J. R. Nadkarni, R. A. Vishwakarma, S. B. Bharate, M. Nivsarkar, and S. Anandjiwala, “The hydroalcoholic extract of Cassia alata (Linn.) leaves and its major compound rhein exhibits antiallergic activity via mast cell stabilization and lipoxygenase inhibition,” Journal of Ethnopharmacology, vol. 141, no. 1, pp. 469–473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Zhu, Z. Liu, H. Huang, Z. Chen, and L. Li, “Rhein inhibits transforming growth factor β1 induced plasminogen activator inhibitor-1 in endothelial cells,” Chinese Medical Journal, vol. 116, no. 3, pp. 354–359, 2003. View at Google Scholar · View at Scopus
  79. H. Li, C. Liang, Q. Chen, and Z. Yang, “Rhein: a potential biological therapeutic drug for intervertebral disc degeneration,” Medical Hypotheses, vol. 77, no. 6, pp. 1105–1107, 2011. View at Publisher · View at Google Scholar · View at Scopus